Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
Go back to Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment| (AMEX: AVAI) | Delayed: 0.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.12 | 52 Week High | $ | |||
| Open | $0.12 | 52 Week Low | $ | |||
| Day High | $0.13 | P/E | N/A | |||
| Day Low | $0.11 | EPS | $ | |||
| Volume | 81,175 | |||||

